申请人:Shionogi & Co., Ltd.
公开号:US20140249306A1
公开(公告)日:2014-09-04
The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent.
wherein, a broken line means the presence or absence of a bond; R
1
is substituted or unsubstituted alkyl etc., R
2
is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R
3
is a substituted or unsubstituted aromatic carbocyclic group; R
4
is a hydrogen atom etc.; R
5
is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R
6
is substituted or unsubstituted alkyl; R
7
is —Z—R
71
etc.; Z is —NR
72
—CO— etc.; R
71
is substituted or unsubstituted alkyl etc.; R
72
is a hydrogen atom etc.
本发明提供了一种具有抗病毒作用的新化合物,特别是具有抑制HIV复制作用的化合物,以及一种药物组合物,特别是一种抗HIV药物。其中,虚线表示键的存在或不存在;R1是取代或未取代的烷基等,R2是取代或未取代的烷氧基等;n为1或2;R3是取代或未取代的芳香环烷基;R4是氢原子等;R5是取代或未取代的芳香环烷基等;Y是单键等;R6是取代或未取代的烷基;R7是—Z—R71等;Z是—NR72—CO—等;R71是取代或未取代的烷基等;R72是氢原子等。